Loading...
Mark & Associates, P.C. and McGinnis, Lochridge & Kilgore, L.L.P. have announced a $15 million verdict against Allergan Inc., the manufacturer of Botox.
The company was found negligent for failing to provide sufficient warnings about potential Botox side effects.
Ray Chester, partner of McGinnis, Lochridge & Kilgore, L.L.P. and lead trial counsel in the case, represented Dr. Sharla Helton in her lawsuit against Allergen, alleging the Botox injections she received in 2006 caused her to suffer botulism poisoning, and eventually led to her being unable to work.
According to today’s article at marketwatch.com, Botox is the trade name for botulinum toxin, type A, which has been described by the Journal of the American Medical Association as “the most poisonous substance known.”
In very small doses, Botox has been used for both therapeutic and cosmetic use. However, Botox can migrate out of the injected muscles and cause severe injuries which constitute, or mimic, the symptoms of botulism.
Jason Mark of Mark & Associates, P.C. was quoted as saying: “This verdict rightly punishes a corporation who clearly put profits ahead of safety. The American public will continue to hold greedy corporations responsible when they put profit margins ahead of safety.”
Get JD Journal in Your Mail
Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!
The law firms are currently representing numerous clients who have been injured as a result of Botox injections. For more information about this verdict and Botox side effects, please visit www.BotoxLegalRights.com.
Founded in 1927, McGinnis, Lochridge & Kilgore, L.L.P. has offices in Austin and Houston, and represents individuals, companies and public institutions in more than 20 focused practice areas and industries.
Mark & Associates, P.C. has offices in Boston, Massachusetts and Long Island, New York and represents victims of defective products, dangerous pharmaceuticals, medical devices and serious accidents.
